BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25218896)

  • 81. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations.
    Ohori NP; Schoedel KE
    Acta Cytol; 2011; 55(6):492-8. PubMed ID: 22156456
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.
    Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?
    Yang SE; Sullivan PS; Zhang J; Govind R; Levin MR; Rao JY; Moatamed NA
    Cancer Cytopathol; 2016 Feb; 124(2):100-9. PubMed ID: 26422098
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
    Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
    Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Both Ultrasound Features and Nuclear Atypia are Associated with Malignancy in Thyroid Nodules with Atypia of Undetermined Significance.
    Eisa N; Khan A; Akhter M; Fensterwald M; Saleem S; Fananapazir G; Campbell MJ
    Ann Surg Oncol; 2018 Dec; 25(13):3913-3918. PubMed ID: 30302643
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
    Wu HH; Rose C; Elsheikh TM
    Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
    Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
    Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules.
    Jin X; Lew M; Pantanowitz L; Smola B; Jing X
    Cancer Cytopathol; 2022 Nov; 130(11):891-898. PubMed ID: 35789120
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.
    Johnson DN; Cavallo AB; Uraizee I; Tanager K; Lastra RR; Antic T; Cipriani NA
    Am J Clin Pathol; 2019 Jan; 151(1):86-94. PubMed ID: 30212867
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies.
    Chung SR; Baek JH; Lee JH; Lee YM; Sung TY; Chung KW; Hong SJ; Jeon MJ; Kim TY; Shong YK; Kim WB; Kim WG; Song DE
    Endocr Pathol; 2019 Jun; 30(2):146-154. PubMed ID: 31044350
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with The Bethesda System for Reporting Thyroid Cytopathology.
    Fazeli R; Schneider EB; Ali SZ; Zeiger MA; Olson MT
    Acta Cytol; 2015; 59(3):225-32. PubMed ID: 26022342
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Consistency in the Distribution of Bethesda System for Reporting Thyroid Cytology Categories Over 9 Years: A Single Institute, Retrospective Study.
    Harris M; Zloczower E; Pinhas S; Allon R; Zornitzki T; Malka L; Cohen Y; Lahav Y; Cohen O
    Endocr Pract; 2024 Jun; 30(6):546-550. PubMed ID: 38570016
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Diagnostic accuracy of Thyroid Imaging Reporting and Data System in the prediction of malignancy in nodules with atypia and follicular lesion of undetermined significance cytologies.
    Baser H; Cakir B; Topaloglu O; Alkan A; Polat SB; Dogan HT; Yazicioğlu MO; Aydin C; Ersoy R
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):584-590. PubMed ID: 27911001
    [TBL] [Abstract][Full Text] [Related]  

  • 96. What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in Turkey.
    Gocun PU; Karakus E; Bulutay P; Akturk M; Akin M; Poyraz A
    Cancer Cytopathol; 2014 Aug; 122(8):604-10. PubMed ID: 24890894
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
    Arnold MA; Nicol KK
    Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Defining thyroid spherules: A benign cytomorphologic feature that mimics microfollicles.
    Costigan DC; Shaar M; Frates MC; Alexander EK; Barletta JA; Cibas ES
    Cancer Cytopathol; 2020 Mar; 128(3):171-176. PubMed ID: 31856389
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Fine-needle aspiration of the thyroid: correlating suspicious cytology results with histological outcomes.
    Baynes AL; Del Rio A; McLean C; Grodski S; Yeung MJ; Johnson WR; Serpell JW
    Ann Surg Oncol; 2014 May; 21(5):1653-8. PubMed ID: 24390657
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Fine-Needle Aspiration Versus Frozen Section in the Evaluation of Malignant Thyroid Nodules in Patients With the Diagnosis of Suspicious for Malignancy or Malignancy by Fine-Needle Aspiration.
    Ye Q; Woo JS; Zhao Q; Wang P; Huang P; Chen L; Li X; Xu K; Yong Y; Sung-Eun Yang S; Rao J
    Arch Pathol Lab Med; 2017 May; 141(5):684-689. PubMed ID: 28447904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.